| scholarly article | Q13442814 |
| P2093 | author name string | Volker Viereck | |
| Jakob Eberhard | |||
| René Moser | |||
| Marianne Gamper | |||
| Jochen Binder | |||
| Carlo Moll | |||
| Joellen Welter | |||
| P2860 | cites work | Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis | Q33436023 |
| Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. | Q34318849 | ||
| B-cell targeting in rheumatoid arthritis and other autoimmune diseases | Q34514813 | ||
| Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis | Q34663038 | ||
| Interstitial cystitis and systemic autoimmune diseases | Q34682243 | ||
| Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal | Q34694719 | ||
| The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study | Q34756462 | ||
| Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens | Q36907584 | ||
| Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis | Q36907771 | ||
| Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome | Q37250416 | ||
| Endoscopic ablation of Hunner's lesions in interstitial cystitis patients. | Q37472527 | ||
| Novel biomarkers for overactive bladder | Q37842130 | ||
| Interstitial cystitis and the overlap with overactive bladder. | Q38042335 | ||
| Mechanisms of action of CD20 antibodies | Q38066195 | ||
| Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome | Q39674933 | ||
| CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis | Q41991545 | ||
| Estimation of the Youden Index and its associated cutoff point | Q46702469 | ||
| Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. | Q47960362 | ||
| Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease | Q49129000 | ||
| Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis | Q68540202 | ||
| Clinical features and spectrum of light microscopic changes in interstitial cystitis | Q68790367 | ||
| Complete transurethral resection of ulcers in classic interstitial cystitis | Q73126051 | ||
| Urine autoantibodies in interstitial cystitis | Q73160633 | ||
| Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder | Q83337237 | ||
| Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome | Q83947318 | ||
| Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells | Q84548333 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.0 Generic | Q44128984 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P921 | main subject | local immune response | Q106596240 |
| P304 | page(s) | 2049-2057 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | International Urogynecology Journal and Pelvic Floor Dysfunction | Q15762178 |
| P1476 | title | Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C | |
| P478 | volume | 24 |
| Q94597080 | Changes in uroplakin expression in the urothelium of patients with ulcerative interstitial cystitis/bladder pain syndrome |
| Q48054557 | Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. |
| Q48161485 | Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder |
| Q30234888 | Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome |
| Q47249076 | Expression of programmed death ligand-1 on bladder tissues is detected in a clinically and histologically well-defined interstitial cystitis cohort. |
| Q44933389 | Have we been led astray by the NGF biomarker data? |
| Q35846928 | Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation |
| Q55171838 | Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis. |
| Q33562538 | Nonkeratinised squamous metaplasia of the urinary bladder in children: a report of case experiences |
| Q28079052 | Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease |
| Q52738809 | Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti-inflammatory effects. |
| Q37051382 | The Expression of Inflammatory Mediators in Bladder Pain Syndrome |
| Q93145668 | Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency |
| Q26749203 | Update on the Pathology and Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: A Review |
Search more.